This post was just published on ZYX Buy Change Alert. RAD is long from $4.95. As of this writing it is trading at $8.18. RAD has a buyout offer from WBA for $9 cash. The stock is trading at a substantial discount to the offer because of the concern that the
This post was just published on ZYX Buy Change Alert. RAD is long from $4.95. The stock is trading at $7.90 as of this writing. RAD Represents A Lucrative Opportunity RAD has received a $9.00 cash offer from WBA. Why is the stock trading at $7.90? The reasons are explained in
I first wrote about a strategy I use when finding beaten-down stock in a February 2014 column titled “An Evergreen Strategy For Unstable Times.” In the column, I illustrated the strategy with an example using Walgreens WBA. Our buy in was around $29. Subsequently, Walgreens hit a high of $97.30.
As per the plan,exited $CVS (CVS Caremark) at $30.69 with profits. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number
As per our earlier post, we are long $CVS from $28.56 based on our funds flow screen being overwhelming positive. The scale in is only 20% of the full position.The stock did not go lower to build a full position. Our trade management plan is to take the profits based
$CVS on earnings conference call this morning highlighted that $CVS expects $4.5Billion in PBM contract losses. Big customer losses are Chrysler, State of NJ, and Coventry. Further, the company expects $1.7Billion loss from Medicare Part D. There are significant implications here presenting themselves to long term investors. Clearly $MHS (Medco